News and Resources



News

Pharma’s Digital Awakening: Research-Ready Health Information And AI To Reduce Cost And Deliver Better Treatments

Clinical Leader | August 2019

Using real-world data to represent the evolving demands and requirements of targeted markets—as demonstrated in the automotive industry—would create drug manufacturing pipelines that are living ecosystems, ushering flexible production into the pharmaceutical industry.

Read more ›

News

Differentiating Oncology Research Pipeline In Today’s Competitive Era

Clinical Leader | August 2019

Big pharma is increasingly doubling down on bets to develop new blockbuster cancer drugs.  Currently, approximately 700 organizations have one or more oncology drugs in late-stage development, and 14 of the world’s largest pharmaceutical companies are focusing at least one-third of their late-stage R&D activity on oncology.

Read more ›

News

Real-World Evidence: Explaining The Current State Of The FDA’s RWE Program

Clinical Leader | February 25, 2019

This article will guide you through the program and what it means for drug developers and explain the potential that real-world data (RWD) offers in developing RWE to significantly and safely accelerate the drug approval process.

Read more ›

Need help with something you don’t see here?
Contact us for more information about our custom solutions.